(Q50310961)

2 March 2018

title

Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism. (English)

1 reference

2 March 2018

0 references

0 references

1 reference

Ahmad Ghanizadeh

1

1 reference

2 March 2018

language of work or name

English

0 references

publication date

10 May 2011

1 reference

2 March 2018

Expert Opinion on Therapeutic Targets

published in

1 reference

2 March 2018

volume

15

1 reference

2 March 2018

issue

6

1 reference

2 March 2018

page(s)

781-783

1 reference

2 March 2018

Oxidative pathways as a drug target for the treatment of autism

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Elevated immune response in the brain of autistic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Immunological findings in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Increased serum levels of glutamate in adult patients with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

May lovastatin target both autism and epilepsy? A novel hypothesized treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Targeting neurotensin as a potential novel approach for the treatment of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Tumor necrosis factor and motoneuronal degeneration: an open problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Signaling via NF-kappaB in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Neuroinflammation and regulation of glial glutamate uptake in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Characterization of the molecular events following impairment of NF-kappaB-driven transcription in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Nuclear factor-kappaB contributes to infarction after permanent focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

NF-kappa B: a crucial transcription factor for glial and neuronal cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

NF-kappaB in the survival and plasticity of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.571212

10.1517/14728222.2011.571212

21 January 2018

Identifiers

DOI

1 reference

2 March 2018

1 reference

2 March 2018